Understanding the Role of Adipose Dysfunction

Obesity remains the most significant preventable risk factor for endometrial cancer worldwide. However, Body Mass Index (BMI) often fails to capture the metabolic complexity of obesity. Recent research focuses on visceral adipose tissue inflammation as a critical driver of tumor progression. This inflammatory state occurs when fat cells grow too large, leading to adipocyte hypertrophy and the formation of "crown-like structures" (CLS). These structures consist of macrophages surrounding dying adipocytes, signaling chronic low-grade inflammation within the omental fat.

Researchers recently conducted a retrospective study of ninety patients with endometrial cancer to evaluate these tissue markers. The study utilized deep learning algorithms to analyze preoperative computed tomography (CT) scans. Pathologists also examined omental biopsies to measure adipocyte size and identify the presence of CLS. Consequently, the team aimed to determine how these microscopic changes correlate with clinical outcomes and adipose distribution.

Impact of Visceral Adipose Tissue Inflammation on Metabolic Health

The findings revealed that adipocyte size strongly correlates with visceral adipose tissue areas. Furthermore, the presence of crown-like structures was significantly associated with hepatic steatosis and higher BMI. While these inflammatory markers did not directly correlate with tumor stage or grade, they showed a robust link with metabolic comorbidities. This suggests that visceral adipose tissue inflammation acts as a bridge between obesity and systemic metabolic dysfunction in cancer patients.

Interestingly, clinicians found that patients with larger fat cells were more likely to suffer from hypertension and insulin resistance. Therefore, evaluating the quality of adipose tissue may provide better insights than simply measuring weight. Although BMI is a useful screening tool, it does not account for the pro-inflammatory environment of visceral fat. This distinction is vital for personalizing care and understanding the long-term health risks for women surviving endometrial cancer.

FAQs

What are crown-like structures in fat tissue?

Crown-like structures (CLS) are microscopic formations where macrophages surround a dead or dying fat cell. They serve as a primary marker for chronic inflammation in adipose tissue.

Why is visceral fat more dangerous than subcutaneous fat in cancer?

Visceral fat is more metabolically active and produces higher levels of pro-inflammatory cytokines. This contributes to insulin resistance and a systemic environment that can promote tumor growth.

Does adipocyte size affect cancer treatment?

While larger adipocytes correlate with metabolic issues like diabetes, current research is still investigating whether they directly impact the efficacy of chemotherapy or radiation in endometrial cancer.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a physician or other qualified health provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. van den Bosch A et al. Visceral adipose tissue inflammation in endometrial cancer. Cancer Treat Res Commun. 2026 Jun 17. doi: undefined. PMID: 42308582.


2. Sæterstøl J et al. Metabolically active visceral fat linked to aggressive endometrial cancer. EANM Congress. 2025 Oct.


3. Crosbie EJ et al. Obesity and endometrial cancer: biological mechanisms and clinical perspectives. Taylor & Francis. 2025 Jun.